Zambart has been awarded the 2020 Research and Development Institution Merit Award by the National Science and Technology Council. This is in recognition of Zambart’s contribution to research and development in Zambia and beyond since 1989.
Wednesday 26 August 2020 (Lusaka, Zambia)—A major TB study currently underway and aimed at investigating methods to reduce TB prevalence and infection in Zambia and South Africa will soon begin testing for COVID-19 using existing mobile TB testing facilities in…
You may view the abstracts from the Workshop under the link below. International Workshop on HIV & Adolescence 2020
Sepo III is a study that aimed to identify and showcase ‘promising practices’ (e.g. policies, programs, services, community initiatives, or other innovations) providing support for young people (0-24 years of age) living with HIV. MEDIA BRIEF LINK
The PopART trial, also known as HPTN 071, delivered community-wide HIV prevention interventions in combination with universal test and treat to 21 communities in Zambia and South Africa. PRESS RELEASE LINK
Zambart Annual Report 2017- 2018
Population Cohort Update The first round of the Population Cohort (PC0) came to an end in March 2015 and during which time 19,711 participants from across all the study communities in Zambia were enrolled. The second round of the Population…
Isoniazid Prevention Therapy (IPT) rolled out in PopART study intervention sites The PopART study embraces the “Test, Treat, and stop HIV approach”, this comes with key interventions for Tuberculosis prevention and treatment which reduce TB morbidity and mortality in people…
